These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8770086)
1. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Mulder P; Elfertak L; Richard V; Compagnon P; Devaux B; Henry JP; Scalbert E; Desché P; Macé B; ThuilleZ C Am J Physiol; 1996 Aug; 271(2 Pt 2):H469-77. PubMed ID: 8770086 [TBL] [Abstract][Full Text] [Related]
2. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition. Mulder P; Compagnon P; Devaux B; Richard V; Henry JP; Elfertak L; Wimart MC; Thibout E; Comoy E; Macé B; Thuillez C Fundam Clin Pharmacol; 1997; 11(3):221-30. PubMed ID: 9243253 [TBL] [Abstract][Full Text] [Related]
3. Vascular and myocardial protective effects of converting enzyme inhibition in experimental heart failure. Mulder P; Devaux B; el Fertak L; Compagnon P; Richard V; Henry JP; Scalbert E; Desché P; Macé B; Thuillez C Am J Cardiol; 1995 Nov; 76(15):28E-33E. PubMed ID: 7484884 [TBL] [Abstract][Full Text] [Related]
4. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Varin R; Mulder P; Tamion F; Richard V; Henry JP; Lallemand F; Lerebours G; Thuillez C Circulation; 2000 Jul; 102(3):351-6. PubMed ID: 10899101 [TBL] [Abstract][Full Text] [Related]
5. Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition. Thuillez C; Mulder P; Elfertak L; Blaysat G; Compagnon P; Henry JP; Richard V; Scalbert E; Desche P Am J Hypertens; 1995 May; 8(5 Pt 2):7S-12S. PubMed ID: 7646844 [TBL] [Abstract][Full Text] [Related]
6. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure. Toyoshima H; Nasa Y; Kohsaka Y; Isayama Y; Yamaguchi F; Sanbe A; Takeo S Br J Pharmacol; 1998 Jan; 123(2):344-52. PubMed ID: 9489624 [TBL] [Abstract][Full Text] [Related]
7. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling. Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865 [TBL] [Abstract][Full Text] [Related]
8. Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits. Hickey H; Makdissi M; Hyland R; Wilks D; Dusting GJ J Mol Cell Cardiol; 1996 Sep; 28(9):1985-94. PubMed ID: 8899557 [TBL] [Abstract][Full Text] [Related]
9. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit. Zhuo J; Casley D; Murone C; Mendelsohn FA J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666 [TBL] [Abstract][Full Text] [Related]
10. Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction. Schäfer A; Fraccarollo D; Hildemann SK; Tas P; Ertl G; Bauersachs J Cardiovasc Res; 2003 Jun; 58(3):655-62. PubMed ID: 12798439 [TBL] [Abstract][Full Text] [Related]
11. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432 [TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism. Schäfer A; Fraccarollo D; Tas P; Schmidt I; Ertl G; Bauersachs J Eur J Heart Fail; 2004 Mar; 6(2):151-9. PubMed ID: 14984722 [TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent and -independent vasoreactivity of rat basilar artery in chronic heart failure. Widder J; Bauersachs J; Fraccarollo D; Ertl G; Schilling L J Cardiovasc Pharmacol; 2000 Apr; 35(4):515-22. PubMed ID: 10774779 [TBL] [Abstract][Full Text] [Related]
15. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction. Yamaguchi F; Sanbe A; Takeo S Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent. Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608 [TBL] [Abstract][Full Text] [Related]
18. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231 [TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors in HF restore canine pulmonary endothelial function and ANG II vasoconstriction. Straeter-Knowlen IM; Dell'italia LJ; Dai J; Hankes GH; Dillon AR; Cartee RE; Pohost GM; Ku DD Am J Physiol; 1999 Nov; 277(5):H1924-30. PubMed ID: 10564148 [TBL] [Abstract][Full Text] [Related]
20. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Vercauteren M; Remy E; Devaux C; Dautreaux B; Henry JP; Bauer F; Mulder P; Hooft van Huijsduijnen R; Bombrun A; Thuillez C; Richard V Circulation; 2006 Dec; 114(23):2498-507. PubMed ID: 17101854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]